Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 35% ± 11% | |
peripheral blood | 17 studies | 32% ± 9% | |
intestine | 9 studies | 25% ± 11% | |
eye | 8 studies | 27% ± 9% | |
kidney | 7 studies | 27% ± 4% | |
brain | 5 studies | 27% ± 8% | |
liver | 5 studies | 28% ± 12% | |
placenta | 4 studies | 30% ± 15% | |
uterus | 4 studies | 42% ± 10% | |
lymph node | 4 studies | 30% ± 16% | |
breast | 4 studies | 30% ± 3% | |
pancreas | 3 studies | 36% ± 11% | |
bone marrow | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 14163.22 | 1445 / 1445 | 100% | 52.43 | 183 / 183 |
uterus | 100% | 12422.54 | 170 / 170 | 100% | 83.51 | 459 / 459 |
kidney | 100% | 9578.82 | 89 / 89 | 100% | 69.95 | 899 / 901 |
ovary | 100% | 10631.58 | 180 / 180 | 100% | 45.12 | 429 / 430 |
thymus | 100% | 10954.54 | 652 / 653 | 100% | 96.65 | 604 / 605 |
prostate | 100% | 9825.06 | 245 / 245 | 99% | 83.76 | 499 / 502 |
intestine | 100% | 9703.56 | 966 / 966 | 99% | 69.01 | 523 / 527 |
skin | 100% | 20909.59 | 1809 / 1809 | 99% | 106.62 | 468 / 472 |
breast | 100% | 12360.14 | 459 / 459 | 99% | 70.11 | 1108 / 1118 |
liver | 100% | 5465.35 | 225 / 226 | 100% | 54.46 | 404 / 406 |
lung | 100% | 13963.57 | 577 / 578 | 99% | 73.60 | 1146 / 1155 |
stomach | 100% | 7334.89 | 359 / 359 | 99% | 57.93 | 283 / 286 |
adrenal gland | 100% | 11747.51 | 258 / 258 | 99% | 60.69 | 227 / 230 |
bladder | 100% | 12871.14 | 21 / 21 | 99% | 75.23 | 497 / 504 |
pancreas | 99% | 4583.52 | 324 / 328 | 99% | 73.52 | 177 / 178 |
brain | 98% | 5478.76 | 2576 / 2642 | 100% | 73.54 | 705 / 705 |
adipose | 100% | 14450.97 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 13847.57 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 126.07 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 105.90 | 29 / 29 |
spleen | 100% | 10490.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 92.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.88 | 1 / 1 |
muscle | 99% | 7150.37 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 10195.32 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 6449.54 | 883 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034315 | Biological process | regulation of Arp2/3 complex-mediated actin nucleation |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0016477 | Biological process | cell migration |
GO_0045765 | Biological process | regulation of angiogenesis |
GO_0032311 | Cellular component | angiogenin-PRI complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0008428 | Molecular function | ribonuclease inhibitor activity |
Gene name | RNH1 |
Protein name | Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1) Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI) |
Synonyms | PRI RNH |
Description | FUNCTION: Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play a role in redox homeostasis. . FUNCTION: Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play a role in redox homeostasis. . FUNCTION: Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play a role in redox homeostasis. . FUNCTION: Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play a role in redox homeostasis. . FUNCTION: Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play a role in redox homeostasis. . |
Accessions | ENST00000356187.9 ENST00000618184.3 ENST00000633418.1 ENST00000632527.1 ENST00000397604.7 ENST00000633464.1 ENST00000631828.1 ENST00000397615.6 ENST00000354420.7 ENST00000529306.5 ENST00000533410.5 ENST00000531540.5 ENST00000529768.5 E9PIK5 ENST00000531149.1 ENST00000631468.1 A0A0J9YXC4 E9PR82 ENST00000632954.1 ENST00000633732.1 E9PIM9 ENST00000527485.5 ENST00000631544.1 E9PLZ3 ENST00000438658.6 ENST00000633287.1 ENST00000529368.5 E9PMI1 ENST00000631652.1 ENST00000532055.5 ENST00000534797.5 ENST00000397614.5 ENST00000525701.5 ENST00000619599.4 ENST00000621211.2 P13489 ENST00000612988.4 ENST00000617351.4 E9PMJ3 ENST00000634214.1 ENST00000524464.5 E9PMA9 H0YCR7 |